VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

55 hedge funds and large institutions have $460M invested in Viridian Therapeutics in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 3 closing their positions.

Holders
55
Holders Change
+16
Holders Change %
+41.03%
% of All Funds
0.85%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
20
Increased
22
Reduced
6
Closed
3
Calls
$1.27M
Puts
–
Net Calls
+$1.27M
Net Calls Change
+$346K

Top Buyers

1
VA
1
VR Adviser
New York
$36.6M
2
APM
2
Avidity Partners Management
Texas
$25.3M
3
BI
3
BVF Inc
California
$37.2M
4
Citadel Advisors
4
Citadel Advisors
Florida
$18.7M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$18.3M

Top Sellers

1
LGM
1
Logos Global Management
California
$0
2
ABG
2
Ally Bridge Group
New York
$12M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$9.35M
4
MS
4
Maven Securities
Jersey
$434K
5
CAM
5
Cormorant Asset Management
Massachusetts
$5.93M
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
$188K +$185K +9,341 +5,399%
Wells Fargo
52
Wells Fargo
California
$9K +$1.37K +74 +18%
LGM
53
Logos Global Management
California
– -$24.7M -1,500,000 Closed
Walleye Trading
54
Walleye Trading
New York
– -$123K -7,500 Closed
RCM
55
RA Capital Management
Massachusetts
– -$17K -1,034 Closed
1 2
3